Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06516640 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Type 2 Continuous Glucose Monitoring Academy

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated February 6, 2026 (before its estimated September 1, 2026 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion date: Jul 1, 2026 to Sep 1, 2026v6
  2. Trial status: Not Yet Recruiting to Recruitingv5 Show 6 more changesShow less
    • Primary completion date: Dec 30, 2025 to Jul 1, 2026
    • Study completion date: Jun 30, 2026 to Dec 30, 2026
    • Start date changed from estimate of May 1, 2025 to Jun 23, 2025
    • Eligibility criteria revised
    • Secondary endpoints: 5 to 7
    • Site details revised
  3. Start date: Apr 1, 2025 to May 1, 2025
    • Site contact updated
    v4
  4. Start date: Jan 20, 2025 to Apr 1, 2025v3
  5. Primary completion date: Jun 30, 2025 to Dec 30, 2025
    • Start date: Aug 1, 2024 to Jan 20, 2025
    • Study sites: 0 to 1
    • Study completion date: Jun 30, 2025 to Jun 30, 2026
    v2
  6. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The goal of this clinical trial is to evaluate the Impact of Continuous Glucose Monitoring Academy Education Curriculum Versus Standard Care on Glycemic Outcomes for Youth With Type 2 Diabetes (T2D): * The first aim is to determine how feasible it is to adapt the Continuous Glucose Monitoring Academy curriculum to teach youth with T2D glucose management strategies. * The second aim is to evaluate the effects of the Continuous Glucose Monitoring Academy metrics. * The third aim is to explore the relationships between these metrics with diabetes distress, diabetes family responsibilities, and process metrics. Participants will join for a total of four weeks of education, followed by a six-month clinical review. They will have access to an online workbook and videos, and will participate in virtual sessions with a diabetes educator who will cover glucose management strategies in-depth. Participants will wear their preferred Continuous Glucose Monitoring system (Dexcom or FreeStyle Libre) provided via insurance and inserted at the baseline visit.
Trial Details
NCT Number NCT06516640
Lead Sponsor Children's Hospital Los Angeles
Collaborators: National Institute on Minority Health and Health Disparities (NIMHD)
Conditions
(from sponsor)		 Type 2 Diabetes
Related terms Diabetes Mellitus, Type 2
Enrollment 60 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov